articleThe LancetMay 1, 2008Closed access

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Karolinska University Hospital · Ospedale Policlinico San Martino · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,705
total citations
FWCI
89.74
Percentile
100%
References
34
Citations per year

Authors

15

Topics & keywords

Keywords
  • Mesenchymal stem cell
  • Medicine
  • Transplantation
  • Stem cell
  • Bone marrow
  • Graft-versus-host disease
  • Adverse effect
  • Ex vivo
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.